Potent, orally active CCK1
(CCK-A) receptor antagonist that displays appetite-stimulant effects. Blocks the anorectic response to CCK-8 and increases food intake in rats following systemic and i.c.v administration.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Effects of intracerebroventricular administration of the CCK1 receptor antagonist devazepide on food intake in rats.
Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.
Duca et al.
Effects of peripheral CCK receptor blockade on food intake in rats.
Reidelberger et al.
Increased food intake and CCK receptor antagonists: beyond abdominal vagal afferents.
The citations listed below are publications that use Tocris products. Selected citations for Devazepide include:
Showing Results 1 - 4 of 4